NC Medical Research Overview
- Year Founded
-
2004
- Status
-
Out of Business
- Employees
-
1
- Latest Deal Type
-
Out of Business
NC Medical Research General Information
Description
Developer of a regenerative drug designed to treat cerebral infarctions. The company's product utilizes human bone marrow-derived mesenchymal stem cells as raw material, using a unique manufacturing process, to reduce cerebral infarction size and improve neural function, enabling healthcare providers to have a more effective method over currently followed thrombolytic therapy to treat cerebral infarctions in patients.
Contact Information
Website
www.ncmr.co.jpCorporate Office
- Shiroyama Trust Tower 17th Floor
- 4-3-1, Toranomon, Minato-ku
- Tokyo, 105-6017
- Japan
Corporate Office
- Shiroyama Trust Tower 17th Floor
- 4-3-1, Toranomon, Minato-ku
- Tokyo, 105-6017
- Japan
NC Medical Research Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Out of Business | 01-Nov-2026 | Completed | Out of Business | |||
| 11. Later Stage VC | 05-Aug-2021 | Completed | Clinical Trials - Phase 2 | |||
| 10. Later Stage VC | 01-Apr-2020 | Completed | Clinical Trials - Phase 2 | |||
| 9. Later Stage VC | 01-Apr-2019 | Completed | Pre-Clinical Trials | |||
| 8. Later Stage VC | 19-Jul-2018 | Completed | Pre-Clinical Trials | |||
| 7. Later Stage VC | 01-Dec-2017 | Completed | Pre-Clinical Trials | |||
| 6. Later Stage VC | 01-Feb-2012 | Completed | Startup | |||
| 5. Later Stage VC | 01-Apr-2011 | Completed | Startup | |||
| 4. Later Stage VC | 01-May-2009 | Completed | Startup | |||
| 3. Early Stage VC | 01-Sep-2008 | Completed | Startup |
NC Medical Research Patents
NC Medical Research Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2017145259-A | Cell therapy for treatment of neurodegeneration | Active | 01-Jun-2017 | ||
| EP-2953473-A1 | Cell therapy for the treatment of neurodegeneration | Active | 06-Feb-2013 | ||
| EP-2953473-A4 | Cell therapy for the treatment of neurodegeneration | Active | 06-Feb-2013 | ||
| EP-3456817-A1 | Cell therapy for the treatment of neurodegeneration | Active | 06-Feb-2013 | ||
| US-10071144-B2 | Cell therapy for the treatment of neurodegeneration | Active | 06-Feb-2013 | A61K38/49 |
NC Medical Research Signals
NC Medical Research FAQs
-
When was NC Medical Research founded?
NC Medical Research was founded in 2004.
-
Where is NC Medical Research headquartered?
NC Medical Research is headquartered in Tokyo, Japan.
-
What is the size of NC Medical Research?
NC Medical Research has 1 total employees.
-
What industry is NC Medical Research in?
NC Medical Research’s primary industry is Drug Discovery.
-
Is NC Medical Research a private or public company?
NC Medical Research is a Private company.
-
What is NC Medical Research’s current revenue?
The current revenue for NC Medical Research is .
-
How much funding has NC Medical Research raised over time?
NC Medical Research has raised $4.54M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process